AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 58 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,382,735 | $56,029,000 | 12.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,117,473 | $85,800,000 | 2.78% |
| Ghost Tree Capital, LLC | 220,000 | $8,914,000 | 1.60% |
| Redmile Group, LLC | 421,133 | $17,064,000 | 1.53% |
| Ghost Tree Capital, LLC | 200,000 | $8,104,000 | 1.46% |
| Green Owl Capital Management, LLC | 45,000 | $1,823,000 | 1.38% |
| RTW INVESTMENTS, LP | 51,300 | $2,079,000 | 0.94% |
| Quantitative Systematic Strategies LLC | 80,458 | $3,208,000 | 0.88% |
| Tourbillon Capital Partners, L.P. | 530,000 | $21,476,000 | 0.55% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 225,380 | $9,132,000 | 0.39% |